What is MoonLake Immunotherapeutics's capex?

MoonLake Immunotherapeutics (MLTX) reported capex of $0 in Q1 2026.

How has MoonLake Immunotherapeutics's capex changed year-over-year?

MoonLake Immunotherapeutics's capex decreased by 100.0% year-over-year, from $35K to $0.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

MoonLake Immunotherapeutics MLTX CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

Oruka Therapeutics, Inc.ORKA

$73K+462%

AnaptysBio, Inc.ANAB

$17K-51.4%

Nektar TherapeuticsNKTR

$18K+800%

Kymera TherapeuticsKYMR

$434K-7.1%

Arcutis Biotherapeutics, Inc.ARQT

$0-100%

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.56B-45.9%

Enterprise value$1.36B-50.0%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's capex?: MoonLake Immunotherapeutics (MLTX) reported capex of $0 in Q1 2026.
How has MoonLake Immunotherapeutics's capex changed year-over-year?: MoonLake Immunotherapeutics's capex decreased by 100.0% year-over-year, from $35K to $0.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.